top
Search terms
Results 71 - 80 of 137 - ordered by :
Pages: 1 ... 5 6 7 8 9 10 11 ... 14
Ehjcvp

Thank you for your interest in spreading the word about European Heart Journal - Cardiovascular Pharmacotherapy. NOTE:

European Heart Journal - Cardiovascular Pharmacotherapy, Erratum

Date : 21/01/2016 Item size : 96711 bytes
Ehjcvp

Undoubtedly, one of the most popular scientific activities within the European Society of Cardiology (ESC) is clinical practice guidelines. [...]there are clinical situations that are not included ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, José L. Zamorano

Date : 01/04/2015 Item size : 100514 bytes
Ehjcvp

An index of new research activity in Cardiovascular Pharmacotherapy can be obtained by listing the number of new updates in the 8th edition of Drugs for the Heart2 that covers all the main areas of ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Lionel H. Opie

Date : 01/04/2015 Item size : 144582 bytes
Ehjcvp

New oral anticoagulants are used in atrial fibrillation (AF) patients to prevent strokes in the primary and secondary prevention settings.1,2 Since AF are reported to be an independent risk factor ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Shinichi Goto, Shinya Goto

Date : 01/04/2015 Item size : 186244 bytes
Ehjcvp

Furthermore, even the truth changes since we perform new studies and since people challenge the truth When I was in Medical School one professor of Medicine told the class, Damn you if you treat ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Stefan Agewall

Date : 01/04/2015 Item size : 97793 bytes
Ehjcvp

Atrial fibrillationIschaemic strokePreventionOral anticoagulationIntroduction Atrial fibrillation (AF) is an expanding epidemic,1 and ischaemic stroke due to cardioembolism remains a trademark ...

European Heart Journal - Cardiovascular Pharmacotherapy, Current Opinion, Thure Filskov Overvad, Peter Brønnum Nielsen, Gregory Y. H. Lip

Date : 01/01/2017 Item size : 256149 bytes
Ehjcvp

Abstract Aims Therapeutic windows for residual platelet reactivity in patients with coronary artery disease on P2Y12 inhibitors were proposed in a consensus document. Conclusions Our results suggest ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Article, Minka J.A. Vries, Heleen J. Bouman, Renske H. Olie, Leo F. Veenstra, Suzanne Zwaveling, Paul W.M. Verhezen, Arina J. ten ...

Date : 01/01/2017 Item size : 286116 bytes
Ehjcvp

[...]authors contemplating submissions of their research in international peer-reviewed journals are now increasingly turning to the EHJCVP. In this comprehensive work, the authors shed light on ...

European Heart Journal - Cardiovascular Pharmacotherapy, Editorials, Dan Atar

Date : 01/01/2017 Item size : 171743 bytes
Ehjcvp

[...]they are used widely (almost indiscriminately) in patients with atherosclerotic vascular disease, and in those at risk of disease. AtherosclerosisLipid lowering drugsPlaque imagingIntroduction ...

European Heart Journal - Cardiovascular Pharmacotherapy, Reviews, Mohammad Alkhalil, Joshua T. Chai, Robin P. Choudhury

Date : 01/01/2017 Item size : 430492 bytes
Ehjcvp

Abstract Aims We aimed to evaluate bleeding risk in clinical practice in patients with atrial fibrillation (AF) being prescribed dabigatran, rivaroxaban, or apixaban compared with warfarin. Using a ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Article, Sigrun Halvorsen, Waleed Ghanima, Ingunn Fride Tvete, Cecilie Hoxmark, PÃ¥l Falck, Oddvar Solli, Christian Jonasson

Date : 01/01/2017 Item size : 240628 bytes